Profilo
Oliver Buck is the founder of OncoBeta GmbH.
He is currently a Trustee at the International Centers for Precision Oncology Foundation and a Member-Supervisory Board at ITM Isotope Technologies Munich SE.
Previously, he served as a Non-Independent Non-Executive Director at Telix Pharmaceuticals Ltd. from 2017 to 2022.
Mr. Buck graduated from Technische Universität München.
Posizioni attive di Oliver Buck
| Società | Posizione | Inizio |
|---|---|---|
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Direttore/Membro del Consiglio | 01/01/2012 |
International Centers for Precision Oncology Foundation | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Oliver Buck
| Società | Posizione | Fine |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 18/05/2022 |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Fondatore | - |
Formazione di Oliver Buck
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Health Technology |
International Centers for Precision Oncology Foundation | |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Health Technology |
















